SCS ASM EXHIBITORS
EXHIBITORS
OUR CONFIRMED 2026 EXHIBITORS
Our exhibitors are an important part of SCS ASM 2026, showcasing the latest products, services, and innovations that support advances in cardiovascular care. Their presence adds value to the meeting experience by connecting attendees with industry partners, new solutions, and emerging developments in the field.
Explore our confirmed exhibitors below and discover the organisations contributing to SCS ASM 2026.
SCS ASM 2026 gratefully acknowledges the support of the following companies.
At Menarini, we are dedicated to invigorating lives. Driven by a firm belief that good health empowers people to unlock their full potential, our cardiovascular portfolio strives to enhance healthcare and uplift the lives of people and communities.
(https://www.menariniapac.com/)
Abbott is a global healthcare leader focused on helping people live healthier, fuller lives through life-changing technologies. Its diverse portfolio spans cardiovascular care, diabetes management, diagnostic testing, nutrition and medicines, supporting better health outcomes for people around the world.
(https://www.abbott.com/en-us/homepagehtt)
Making a positive difference in the world is at the heart of what we do at Amgen—and it goes beyond making vital medicines
(amgen.com)
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. AstraZeneca Singapore advances innovative medicines to improve and save lives.
(https://www.astrazeneca.com/)
At Boehringer Ingelheim, we strive to improve the health of humans and animals – for generations. We work together with integrity and are guided by a shared purpose that defines who we are and what we do.
(https://www.boehringer-ingelheim.com/)
Bristol Myers Squibb is a global biopharmaceutical company that is focused on discovering, developing, and delivering innovative medicines to help patients prevail over serious diseases. It focuses on driving scientific and academic excellence while rigorously developing innovative, high-quality treatments to meet patient needs.
(https://www.bms.com/sg)
DKSH is a leading Market Expansion Services provider for healthcare companies in Asia Pacific and Switzerland. With nearly 160 years of experience, they offer integrated solutions including registration, marketing, sales, distribution, and more through their extensive network of healthcare outlets and developing channels.
(https://www.dksh.com/sg-en/home)
DKSH Healthcare is a strategic healthcare business partner delivering sustainable growth for pharmaceutical, over-the-counter and consumer health, and medical device brands and companies. We bring life-saving and life-changing drugs, medicines, supplements, vaccines, treatments, and medical devices to patients –improving patient outcomes by providing our partners with a full range of commercial outsourcing and market expansion services
(https://www.dksh.com/sg-en/home/healthcare)
At GSK, we combine science, technology, and talent to prevent and treat disease through specialty medicines and vaccines, focusing on respiratory, immunology, oncology, HIV, and infectious diseases. Our Ahead Together strategy aims to intervene early, changing disease outcomes and supporting healthcare systems.
(https://www.gsk.com/en-gb/locations/singapore/)
Medison is the creator and leader of the first global commercialization platform designed to accelerate patient access to breakthrough therapies developed by biotechs, fulfilling our vision of closing the access gap for patients with rare and severe diseases across international markets.
(https://www.medisonpharma.com/)
At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities.
(https://www.msd.com/)
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
(https://www.novartis.com/sg-en/)
Novo Nordisk is a global healthcare company powered by 77,400 changemakers across 80 countries, united by a singular purpose: to defeat serious chronic diseases. Our therapies reach patients in nearly 170 markets—and our impact is accelerating fast. In Singapore, we’ve been driving change since 1997. What began as a commitment to diabetes care has evolved into a relentless pursuit of breakthroughs—crafted for patients, championed by doctors. We’re here to bend the curve on chronic disease. We’ll continue to push the boundaries of care through science that speaks, partnerships that endure, and a shared commitment to better health. We’re not going anywhere—not until chronic disease is no longer a life sentence for this generation and the next.
(https://www.novonordisk.sg/)
OMRON Healthcare is dedicated to addressing key health challenges, from heart health to chronic pain and respiratory care. Through innovative technology and digital solutions, we empower individuals and support preventive care. Backed by a trusted legacy and strong healthcare partnerships, we aim to help people live healthier, more fulfilling lives.
At Organon, we are here for her health. Our goal is to be the leading women’s health company in the world by focusing on women’s everyday health needs.
Today, our company has a portfolio of over 60 medicines and products that we deliver to patients in ~140 markets around the world. But we know there is so much we can do to support the health of women. Therefore, we will put women at the center of everything we do, striving to listen and understand her healthcare needs, big and small, to ensure we provide medicines and other products that allow her to live a better and healthier every day.
(https://www.organon.com/singapore/)
Otsuka Pharmaceutical was established in 1964. At Otsuka Pharmaceutical, we are committed to a holistic approach to health and well-being of people and are striving to create innovative, thoroughly-original pharmaceutical and nutraceutical products based on our corporate philosophy “Otsuka-people creating new products for better health worldwide
Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products.
(https://www.pfizer.com.sg/)
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
(https://www.sanofi.com/en/singapore)
Servier leverages its independence to pursue a long-term vision focused on therapeutic progress. By prioritizing patients and healthcare professionals, we drive meaningful innovation while remaining dedicated to positive societal and environmental impact. Together, we are creating the future of healthcare, serving the needs of both today and tomorrow.
(https://servier.com/en/servier/)
In November 2020, Viatris was formed through the combination of Mylan and Upjohn, with a mission of empowering people worldwide to live healthier at every stage of life.
Viatris’ name is rooted in Latin and embodies a vision of providing a path (“VIA”) to three (“TRIS”) critical goals: expanding access to medicines, leading by innovating to meet patient needs, and being a trusted partner for the healthcare community worldwide.
We produce medicines for patients across a broad range of major therapeutic areas, spanning both noncommunicable and infectious diseases.We provide access to our of high-quality medicines in more than 165 countries and territories.
(https://www.viatris.com/en)
Registration info
Secure your place and join leading experts in cardiology from around the world. Early bird registration is now open, offering the best rates and access to valuable networking opportunities, expert-led sessions, and more. Register early to enjoy exclusive savings and be part of SCS ASM 2026.
Venue Info
SCS ASM 2026 will be held at the Grand Copthorne Waterfront Hotel Singapore, offering a sophisticated and welcoming setting for this year’s meeting. Conveniently located along the Singapore River, the venue combines modern event spaces with a comfortable atmosphere, creating an ideal environment for learning, collaboration, and connection.
PROGRAMME OVERVIEW
The SCS ASM 2026 programme offers a comprehensive line-up of scientific sessions, expert discussions, and networking opportunities. Designed to highlight the latest developments in cardiovascular medicine, the meeting provides delegates with valuable insights, practical knowledge, and meaningful opportunities for professional exchange.